Evaluate the Efficacy of a Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)

Research unit

INNOSUISSE

Project number

35796.1 IP-LS

Project title

Evaluate the Efficacy of a Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Category	Text
Short description (German)	Evaluate the Efficacy of a Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)
Short description (English)	Evaluate the Efficacy of a Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)
Abstract (German)	SBC003 is a synthetic natural neuroprotective agent showing promising effects in Amyotrophic Lateral Sclerosis (ALS) models. The objective of this project is to further evaluate the efficacy and mode of action of SBC003 in both in vivo and in vitro ALS disease models.